RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $136
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has maintained an Outperform rating on Tenet Healthcare (NYSE:THC) and increased the price target from $109 to $136.
May 01, 2024 | 5:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has maintained an Outperform rating on Tenet Healthcare and raised the price target from $109 to $136.
The increase in price target by RBC Capital suggests a positive outlook on Tenet Healthcare's future performance. This endorsement from a reputable analyst could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100